Mohammed Sayed Abdel-Aziz

Dr. Mohammed Sayed Abdel-Aziz is a prominent researcher at Egypt's National Research Centre (NRC), contributing to chemistry and microbiology since 1998 through innovative compound synthesis for antimicrobial therapy and enzyme production.

His research spans drug design, enzyme characterization, and toxicology mitigation, with notable work on sulfonamide-tethered coumarin derivatives, quinoline-based DNA gyrase inhibitors, and bioactive metabolites from endophytic fungi. This interdisciplinary approach bridges chemical synthesis and biological evaluation to address health challenges.

Analysis of his publications (2011-2020) reveals consistent focus on natural product chemistry, particularly antimicrobial agent discovery and toxin countermeasures. Key themes include aflatoxin B1 mitigation, silver nanoparticle toxicity reduction, and fungal enzyme applications in textiles.

Dr. Abdel-Aziz has secured significant research funding from the National Institutes of Health, National Science Foundation, Natural Environment Research Council, and Carnegie Corporation of New York, enabling extensive international collaborations across Egypt, Niger, and global institutions.